Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol.

A new tool will allow researchers to identify proteins involved in DNA replication and damage repair, processes that go awry in cancer.

New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.

A molecule detectable in urine may be helpful in diagnosing colon cancer.

Some patients may need a combo of medications to combat a condition that causes dizziness.

Shyness may be caused by deficits in the brain.

Abnormal levels of fatty acids in the blood and tissues of patients with cystic fibrosis may be reversed by supplementation with the fatty acids DHA and EPA.